These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3537128)

  • 1. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
    Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
    J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.
    Mountz JD; Gause WC; Finkelman FD; Steinberg AD
    J Immunol; 1988 May; 140(9):2943-9. PubMed ID: 2834447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of elevated c-myb expression in the abnormal L3T4-, Lyt-2- T lymphocytes of autoimmune mice.
    Evans JL; Boyle WJ; Ting JP
    J Immunol; 1987 Nov; 139(10):3497-505. PubMed ID: 3316384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paul-Bunnell antigen in murine T cell differentiation: abnormal expression in MRL/Mp-lpr/lpr mice.
    Katagiri T; Tomiyama H; Kano K
    J Immunol; 1986 Feb; 136(3):913-9. PubMed ID: 3079803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
    Budd RC; Schreyer M; Miescher GC; MacDonald HR
    J Immunol; 1987 Oct; 139(7):2200-10. PubMed ID: 3498754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
    Palacios R
    Eur J Immunol; 1984 Jul; 14(7):599-605. PubMed ID: 6430708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive T cells with atypical MHC restriction from MRL-lpr/lpr mice: forbidden clones revisited.
    Naparstek Y; Baur K; Reis MD; Breitman L; Mak TW; Schwartz RS; Madaio MP
    J Mol Cell Immunol; 1988; 4(1):35-43. PubMed ID: 2471535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the J11d marker on peripheral T lymphocytes of MRL-lpr/lpr mice.
    Seth A; Pyle RH; Nagarkatti M; Nagarkatti PS
    J Immunol; 1988 Aug; 141(4):1120-5. PubMed ID: 2899601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor gene expression in autoimmune mice.
    Mountz JD; Huppi KE; Seldin MF; Mushinski JF; Steinberg AD
    J Immunol; 1986 Aug; 137(3):1029-36. PubMed ID: 3487582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of lymphoproliferation in MRL-lpr/lpr mice.
    Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
    J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O; Shlomchik MJ
    J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice.
    Rosenberg YJ; Malek TR; Schaeffer DE; Santoro TJ; Mark GE; Steinberg AD; Mountz JD
    J Immunol; 1985 May; 134(5):3120-3. PubMed ID: 3920313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.